PF-08634404, YERVOY 5 mg/ml concentrate for solution for infusion clinical trials

C6461013 - An Interventional Open-label Phase 1b/2 Study to Evaluate Safety, Pharmacokinetics, and Preliminary Efficacy of PF-08634404 as Monotherapy and Combination Therapy in Adult Participants With Unresectable Locally Advanced or Metastatic Hepatocellular Carcinoma

This study is testing a new medicine, PF-08634404, alone and with another drug called YERVOY, for adults with advanced liver cancer that cannot be removed by surgery. It aims to see if the new medicine is safe, how it moves through the body, and if it can help shrink the cancer.